Press Release

L'odyssée vers la survie du cancer du sein métastatique : Le programme de recherche académique AURORA

International Clinical Trials Day 2023

First results from POSITIVE study: Young women with breast can safely have a baby

AURORA, the first international molecular screening programme for metastatic breast cancer, presented at IMPAKT Breast Cancer Conference

New Treatment Option for Young Women with Hormone-Sensitive Breast Cancer

ALTTO Test of Dual HER2 Blockade Finds Single Agent – Trastuzumab – Remains the Gold Standard

Opening of international PANACEA study of patients with HER2+ breast cancer

Belgian Dr. Martine Piccart has received prestigious international Brinker Award for Scientific Distinction in Clinical Research

Pfizer Awards Breast International Group (BIG) $1 Million Research Grant to Support Non‐Drug Related Breast Cancer Research

New England Journal of Medicine” publishes results of MINDACT clinical trial The 70-gene test (Mammaprint®) can significantly reduce use of chemotherapy among breast cancer patients and has the potential to change clinical practice: 46% of early stage breast cancer patients classified as high-risk by traditional methods can avoid chemotherapy